We are monitoring the impact of COVID-19 on MEA Mycoplasma Testing Market Get in touch with us for detailed analysis Know More
Share on

MEA Mycoplasma Testing Market Research Report - Segmented By Product, Technique, Application, End-User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 3525
Pages: 137

MEA Mycoplasma Testing Market Size (2022 to 2027)

The size of the mycoplasma testing market in the Middle East and Africa is predicted to worth USD 95.09 Million by 2027 and USD 64.03 Million in 2022, growing at a CAGR of 8.23% from 2022 to 2027.

MARKET DRIVERS:

Factors such as growing spending by biopharmaceutical companies on R&D, increasing government initiatives and research funding, technological advancements, growing demand for rapid, accurate, and affordable tests, and increasing contamination of cell cultures further stimulate the MEA mycoplasma testing market. Furthermore, contamination by mycoplasmas is responsible for developing toxins and alterations in the formation of metabolites in cell culture. Hence, it plays a vital role in the biopharmaceutical industries.

The growth of the MEA mycoplasma testing market is further driven by the growth of the biotechnology and pharmaceutical sector. Moreover, an increase in the contamination of cultures, technological advancements, and increased investments by organizations in research and development activities contributes to the growth of the mycoplasma testing market.

MARKET RESTRAINTS:

The high cost of the instruments and keeping the instruments in proper storage condition is expected to restrain the market's growth during the forecast period. In addition, there are some strict government regulations in several developed and emerging countries and a high degree of consolidation for new entrants, which are among the major impediments to the growth of the MEA mycoplasma testing market.

MARKET OPPORTUNITIES:

The prevalence of mycoplasma pneumonia co-infection in COVID-19 patients is expected to drive the market for mycoplasma testing during the forecast period. In addition, the presence of M. pneumonia co-infection increases the need to test patients for COVID-19, increasing the demand for routine diagnostic tests for respiratory pathogens such as M. pneumonia.

Co-infections in COVID-19 cases have a significant likelihood of being caused by Mycoplasma disease. For example, according to a 2020 study published in the Archives of Medical Laboratory Sciences, co-infection with M. pneumonia ranged from 1% to 44.6% depending on the population and diagnostic tests used and the combined prevalence of M. pneumoniae. Infection among COVID-19 patients was reported by 19%.

MARKET CHALLENGES:

Mycoplasma easily spreads through droplets during cell culture and can survive in a dry form for months. Mycoplasma contamination is difficult to see under a microscope and requires specific tests to be detected. Contamination can have an immense impact on the experimental work hence is technique sensitive and require skilled workers.

This research report on the Latin America Mycoplasma Testing Market has been segmented and sub-segmented into the following categories:

By Product: 

  • Kits & Reagent       
    1. PCR Assays
    2. Nucleic Acid Detection Kits
    3. Elimination Kits & Reagents
    4. Stains
    5. Standards & Controls
    6. Other Kits & Reagents
  • Instruments           
  • Services    

By Technique: 

  • PCR            
  • ELSA           
  • Direct Assays          
  • Indirect Assays      
  • Microbial culture techniques           
  • Enzymatic Methods            
  • DNA Staining       

By Application: 

  • Cell Line Testing
  • Virus Testing
  • End-Of-Production Cell Testing
  • Others

By End-User: 

  • Pharmaceutical Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Cell Banks

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the Middle East is expected to grow at a healthy growth rate owing to its well-established healthcare industry and the increasing prevalence of chronic diseases in the region. Saudi Arabia is expected to play a leading role in the Middle East and Africa market due to the rise in prevalence of mycoplasma infections amongst young children in the region. Other growth factors in this region are global biotechnology companies and pharmaceutical players and increased investment. In addition, due to increasing technological advancements in cell culture and government-funded development assistance for drug research, growth is seen in populated areas such as South Africa, Kuwait, and the United Arab Emirates.

While less developed regions such as North Africa and Turkey are expected to show comparatively lower growth, this is due to rising healthcare expenditure and rapid, sensitive testing.

KEY MARKET PLAYERS:

PromoCell GmbH, Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Lonza Group Ltd., Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, and WuXi AppTec are a few of the notable companies in the MEA mycoplasma testing market.

1.Introduction         

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Product                        

       5.1.1 Introduction           

       5.1.2 Kits & Reagent       

       5.1.3 Instruments           

       5.1.4 Services    

       5.1.5  Y-o-Y Growth Analysis, By Product              

       5.1.6  Market Attractiveness Analysis, By Product            

       5.1.7  Market Share Analysis, By  Product             

                5.2 Technique                   

       5.2.1 Introduction           

       5.2.2 PCR            

       5.2.3 ELSA           

       5.2.4 Direct Assays          

       5.2.5 Indirect Assays      

       5.2.6 Microbial culture techniques           

       5.2.7 Enzymatic Methods            

       5.2.8 DNA Staining          

       5.2.9 Y-o-Y Growth Analysis, By Technique          

       5.2.10 Market Attractiveness Analysis, By Technique      

       5.2.11 Market Share Analysis, By Technique       

                5.3 Application                 

       5.3.1 Introduction           

       5.3.2 Cell Line Testing    

       5.3.3 Virus Testing          

       5.3.4 End-Of-Production Cell Testing      

       5.3.5 Other Applications               

       5.3.6 Y-o-Y Growth Analysis, By Application         

       5.3.7  Market Attractiveness Analysis, By Application      

       5.3.8  Market Share Analysis, By Application       

                5.4 End-User                      

       5.4.1 Introduction           

       5.4.2 Pharmaceutical Companies              

       5.4.3 Contract Research Organizations   

       5.4.4 Academic Research Institutes         

       5.4.5 Cell Banks

       5.4.6 Y-o-Y Growth Analysis, By End User             

       5.4.7 Market Attractiveness Analysis, By End User           

       5.4.8 Market Share Analysis, By End User             

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Product

                       6.1.3.3 By Technique

                       6.1.3.4 By Application

                       6.1.3.5 By End User

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Product

                       6.1.4.3 By Technique

                       6.1.4.4 By Application

                       6.1.4.5 By End User

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Product

                       6.1.5.3 By Technique

                       6.1.5.4 By Application

                       6.1.5.5 By End User

                6.2 Middle-East       

                6.3 Africa   

7.Strategic Analysis               

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                

                8.1 Thermo Fisher Scientific Inc.      

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Minerva Biolabs GmbH 

                8.3 Charles River Laboratories International                        

                8.4 Gibraltar Laboratories   

                8.5 Sartorius AG      

                8.6 Lonza Group Ltd.                      

                8.7 Merck KGaA      

                8.8 Roche Diagnostics                    

                8.9 SGS S.A.                       

                8.10 American Type Culture Collection                  

                8.11 InvivoGen                 

                8.12 PromoCell GmbH                   

                8.13 Biological Industries Israel Beit Haemek Ltd.     

                8.14 WuXi AppTec  

9.Competitive Landscape                   

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10.Market Outlook and Investment Opportunities                 

Appendix                  

                a) List of Tables                

                b) List of Figures     

  1. Middle East and Africa Mycoplasma Testing Market By Product, From 2022 - 2027 ( USD Billion )
  2. Middle East and Africa Kits & Reagent Market By Region, From 2022 - 2027 ( USD Billion )
  3. Middle East and Africa Instruments      Market By Region, From 2022 - 2027 ( USD Billion )
  4. Middle East and Africa Services  Market By Region, From 2022 - 2027 ( USD Billion )
  5. Middle East and Africa Mycoplasma Testing Market By Technique, From 2022 - 2027 ( USD Billion )
  6. Middle East and Africa PCR  Market By Region, From 2022 - 2027 ( USD Billion )
  7. Middle East and Africa ELSA   Market By Region, From 2022 - 2027 ( USD Billion )
  8. Middle East and Africa Direct Assays Market By Region, From 2022 - 2027 ( USD Billion )
  9. Middle East and Africa Indirect Assays Market By Region, From 2022 - 2027 ( USD Billion )
  10. Middle East and Africa Microbial culture techniques Market By Region, From 2022 - 2027 ( USD Billion )
  11. Middle East and Africa Enzymatic Methods Market By Region, From 2022 - 2027 ( USD Billion )
  12. Middle East and Africa DNA Staining Market By Region, From 2022 - 2027 ( USD Billion )
  13. Middle East and Africa Mycoplasma Testing Market By Application, From 2022 - 2027 ( USD Billion )
  14. Middle East and Africa Cell Line Testing Market By Region, From 2022 - 2027 ( USD Billion )
  15. Middle East and Africa Virus Testing Market By Region, From 2022 - 2027 ( USD Billion )
  16. Middle East and Africa Cell Testing Market By Region, From 2022 - 2027 ( USD Billion )
  17. Middle East and Africa Mycoplasma Testing Market By  End User, From 2022 - 2027 ( USD Billion )
  18. Middle East and Africa Pharmaceutical Companies Market By Region, From 2022 - 2027 ( USD Billion )
  19. Middle East and Africa Contract Research Organizations  Market By Region, From 2022 - 2027 ( USD Billion )
  20. Middle East and Africa Academic Research Institutes Market By Region, From 2022 - 2027 ( USD Billion )
  21. Middle East and Africa Cell Banks Market By Region, From 2022 - 2027 ( USD Billion )
  22. Middle East Mycoplasma Testing Market By Product, From 2022 - 2027 ( USD Billion )
  23. Middle East Mycoplasma Testing Market By Technique, From 2022 - 2027 ( USD Billion )
  24. Middle East Mycoplasma Testing Market By Application, From 2022 - 2027 ( USD Billion )
  25. Middle East Mycoplasma Testing Market By  End User, From 2022 - 2027 ( USD Billion )
  26. Africa Mycoplasma Testing Market By Product, From 2022 - 2027 ( USD Billion )
  27. Africa Mycoplasma Testing Market By Technique, From 2022 - 2027 ( USD Billion )
  28. Africa Mycoplasma Testing Market By Application, From 2022 - 2027 ( USD Billion )
  29. Africa Mycoplasma Testing Market By  End User, From 2022 - 2027 ( USD Billion )
  30. Middle East and Africa Mycoplasma Testing  Market By Kits & Reagent, From 2022 - 2027 ( USD Million )
  31. Middle East and Africa PCR Assays Market By Region, From 2022 - 2027 ( USD Million )
  32. Middle East and Africa Nucleic Acid Detection Kits Market By Region, From 2022 - 2027 ( USD Million )
  33. Middle East and Africa Elimination Kits & Reagents Market By Region, From 2022 - 2027 ( USD Million )
  34. Middle East and Africa Stains Market By Region, From 2022 - 2027 ( USD Million )
  35. Middle East and Africa Standards & Controls Market By Region, From 2022 - 2027 ( USD Million )
  36. Middle East and Africa Other Kits & Reagents Market By Region, From 2022 - 2027 ( USD Million )
  37. Middle East Mycoplasma Testing  Market By Kits & Reagent, From 2022 - 2027 ( USD Million )
  38. Africa Mycoplasma Testing  Market By Kits & Reagent, From 2022 - 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample